Changeflow GovPing Securities & Markets Late 10-K Filing Notification - MediXall Group
Routine Notice Added Final

Late 10-K Filing Notification - MediXall Group

Favicon for changeflow.com SEC EDGAR: Late Filing Notices
Published December 25th, 2025
Detected March 31st, 2026
Email

Summary

MediXall Group, Inc. filed Form 12b-25 with the SEC notifying the agency that the company's annual report on Form 10-K for the period ended December 31, 2025 cannot be filed within the prescribed time period. The company cited that certain financial and other information necessary for full completion could not be provided without unreasonable effort or expense.

What changed

MediXall Group, Inc. (SEC File 333-194337) submitted a Notification of Late Filing on Form 12b-25 for its annual report on Form 10-K covering the period ended December 31, 2025. The company stated that it could not complete the required financial and other information within the prescribed deadline without unreasonable effort or expense. The filing indicates the company will file within 15 calendar days following the prescribed due date. The notification also reveals the company is delinquent in filing the 2024 Form 10-K and possibly other periodic reports.

Companies receiving this notification should note that Form 12b-25 provides only a brief extension period and does not exempt the registrant from reporting obligations. Extended delinquency in SEC filings can lead to delisting proceedings and other enforcement consequences. Compliance teams at other public companies should use this as a reminder to monitor their own filing calendars closely and file extensions promptly if delays are anticipated.

Source document (simplified)

NT 10-K 1 mdxl_12b25.htm NOTIFICATION OF LATE FILING

| | | | |
| | UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549 | | |
| | | | |
| | | | |
| | | | |
| | FORM 12b-25 | SEC FILE NUMBER

333-194337 | |
| | NOTIFICATION OF LATE FILING | CUSIP NUMBER | |

| | | | | | | | | | | | | | | |
| (Check one): | ü | Form 10-K | | Form 20-F | | Form 11-K | | Form 10-Q | | Form 10-D | | Form N-CEN | | Form N-CSR |

| | | | | |
| | For Period Ended: | | December
31, 2025 | |
| | | | | |
| | | Transition Report on Form 10-K | | |
| | | | | |
| | | Transition Report on Form 20-F | | |
| | | | | |
| | | Transition Report on Form 11-K | | |
| | | | | |
| | | Transition Report on Form 10-Q | | |
| | | | | |
| | For the Transition Period Ended: | | | |
| | | | | |

| |
| Read Instructions (on back page) Before Preparing Form. Please Print or Type. |
| Nothing in this form shall be construed to imply that the Commission has verified any information contained herein. |
| If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates: |
| |
| |
| PART I — REGISTRANT INFORMATION |

| |
| MediXall Group,
Inc. |
| Full Name of Registrant |
| |
| |
| Former Name if Applicable |
| |
| 104 N 4th St. |
| Address of Principal Executive Office (Street
and Number)
|
| |
| Leesburg, FL
34748 |
| City, State and Zip Code |

| |

| |

| |
| PART II — RULES 12b-25(b) AND (c) |
| |
| If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate) |

| | | | | | |
| | | | | (a) | The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense; |
| | (b) | The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-CEN or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and | | | |
| ü | | | | | |
| | | | | | |
| | (c) | The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable. | | | |

| |
| PART III — NARRATIVE |
| |
| State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-CEN, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period. (Attach extra Sheets if Needed) |
| |
| Certain financial and other information necessary for
an accurate and full completion of the Report could not be provided within the prescribed time period without unreasonable effort
or expense. |

| |
| PART IV — OTHER INFORMATION |

| | | | | | | | | | |
| (1) | Name and telephone number of person to contact in regard to this notification | | | | | | | | |
| | | | | | | | | | |
| | Travis
Jackson | | 800 | | 381-1787 | | | | |
| | (Name) | | (Area Code) | | (Telephone Number) | | | | |
| | | | | | | | | | |
| (2) | Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s). | | | | | | | | |
| Yes | | | | | | | No | ü | |
| | The Company is
delinquent in filing the 2024 Form 10-K and the Form 10-Q for the periods ended March 31, 2025, June 30, 2025 and September 30,
2025. We are in the process of preparing the respective Form 10-Q’s for filing with the Securities and Exchange Commission. | | | | | | | | |
| | | | | | | | | | |
| (3) | Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof? | | | | | | | | |
| Yes | | | | | | | No | ü | |
| | | | | | | | | | |
| | If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made. | | | | | | | | |
| | | | | | | | | | |

| | | | | | | |
| | | | | | | |
| | MediXall Group, Inc. | | | | | |
| | (Name of Registrant as Specified in Charter) | | | | | |
| | | | | | | |
| | has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized. | | | | | |
| | | | | | | |
| Date: | | March 31, 2026 | | | By: | /s/ Travis Jackson |
| | | | | | | Travis Jackson, Chief Financial Officer |
| | | | | | | |

CFR references

17 CFR 249.310 17 CFR 240.12b-25

Named provisions

Part I - Registrant Information Part II - Rules 12b-25(b) and (c) Part III - Narrative Part IV - Other Information

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
SEC
Published
December 25th, 2025
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
Form 12b-25 / SEC File 333-194337
Docket
333-194337

Who this affects

Applies to
Public companies
Industry sector
4231 Wholesale Trade
Activity scope
Annual Report Filing Securities Disclosure
Threshold
Public companies required to file periodic reports under Section 13 or 15(d) of the Securities Exchange Act of 1934
Geographic scope
United States US

Taxonomy

Primary area
Securities
Operational domain
Legal, Compliance
Compliance frameworks
SOX
Topics
Corporate Governance Financial Services

Get Securities & Markets alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when SEC EDGAR: Late Filing Notices publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.